FDA Approves Actavis’s Generic Cozaar

Actavis Group Oct. 12 announced that the Food and Drug Administration has approved its generic version of Merck’s Cozaar (losartan potassium tablets) in 25 mg, 50 mg, and 100 mg strengths.

Cozaar is indicated for the treatment of high blood pressure and stroke, according to FDA. Losartan potassium tablets had U.S. sales of approximately $940 million for the 12 months ending June 30, according to IMS Health. Actavis did not say when it would start selling the generic.

The approval of a generic of Cozaar has been the subject of extensive litigation. Most recently, generic drug company Apotex sought Supreme ...